We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTEX icon
1876
VTEX
VTEX
$745M
$1.23M 0.01%
+60,013
New +$1.5M
SMP icon
1877
Standard Motor Products
SMP
$897M
$1.23M 0.01%
+28,207
New +$1.21M
XME icon
1878
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$3.9B
$1.23M 0.01%
+29,500
New +$1.28M
BBW icon
1879
Build-A-Bear
BBW
$443M
$1.23M 0.01%
72,687
+37,987
+109% +$623K
ATC
1880
DELISTED
Atotech Limited
ATC
$1.23M 0.01%
50,938
-72,415
-59% -$1.74M
CLAA.WS
1881
CALL
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$1.23M 0.01%
125,344
SHG icon
1882
Shinhan Financial Group
SHG
$32.8B
$1.23M 0.01%
36,398
-82,593
-69% -$2.76M
FRLN
1883
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$1.23M 0.01%
+23,742
New +$1.69M
CPUH.WS
1884
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1.22M 0.01%
125,233
GPI icon
1885
Group 1 Automotive
GPI
$4.17B
$1.22M 0.01%
6,511
-8,092
-55% -$1.37M
LGND icon
1886
Ligand Pharmaceuticals
LGND
$5.94B
$1.22M 0.01%
+14,068
New +$1.09M
NWL icon
1887
Newell Brands
NWL
$2.24B
$1.22M 0.01%
+55,258
New +$1.41M
WPRT
1888
Westport Fuel Systems
WPRT
$32.9M
$1.22M 0.01%
37,152
+230
+0.6% +$9.26K
ICUCW
1889
CALL
SeaStar Medical Holding Corp Warrant
ICUCW
$1.22M 0.01%
121,528
+25,524
+27% +$12.5K
OPALW
1890
CALL
DELISTED
OPAL Fuels Inc. Warrant
OPALW
$1.22M 0.01%
124,995
AL
1891
DELISTED
Air Lease Corp
AL
$1.22M 0.01%
+30,975
New +$1.26M
FNKO icon
1892
Funko
FNKO
$355M
$1.22M 0.01%
66,965
-148,390
-69% -$2.8M
PKE icon
1893
Park Aerospace
PKE
$747M
$1.22M 0.01%
+89,106
New +$1.31M
EOCW.WS
1894
CALL
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$1.22M 0.01%
+124,995
New +$134K
ORCL icon
1895
Oracle
ORCL
$346B
$1.22M 0.01%
13,939
+12,367
+787% +$1.09M
EA icon
1896
Electronic Arts
EA
$52.4B
$1.21M 0.01%
8,529
-13,122
-61% -$1.84M
MACA
1897
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
$1.21M 0.01%
+125,037
New +$1.21M
TISI icon
1898
Team
TISI
$80.6M
$1.21M 0.01%
40,171
+38,418
+2,192% +$1.85M
BIOTW
1899
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$1.21M 0.01%
124,022
+24,029
+24% +$17.9K
FRXB.WS
1900
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$1.21M 0.01%
123,581

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.